Title : Combination of ShuangDan Capsule and Sorafenib Inhibits Tumor Growth and Angiogenesis in Hepatocellular Carcinoma Via PI3K/Akt/mTORC1 Pathway.

Pub. Date : 2022 Jan-Dec

PMID : 35234063






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combination of ShuangDan Capsule and Sorafenib Inhibits Tumor Growth and Angiogenesis in Hepatocellular Carcinoma Via PI3K/Akt/mTORC1 Pathway. Sorafenib CREB regulated transcription coactivator 1 Mus musculus